Tyrosinemia, Type I
Oncology·MeSH: Arginine-Glycine Amidinotransferase Deficiency
Prevalence
0.5 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Tyrosinemia, Type I?
There are 2 clinical trials targeting Tyrosinemia, Type I tracked by BioSniper.
What is the prevalence of Tyrosinemia, Type I?
The estimated prevalence of Tyrosinemia, Type I is approximately 0.5 per 100,000 population.
Deep-dive into Tyrosinemia, Type I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis